Klotho and fibroblast growth factor 23 (FGF23) are early laboratory parameters of chronic kidney disease (CKD)-mineral bone disorder (MBD), and the Klotho/FGF23 axis plays an important role in this disorder (1, 2). This evidence concerns the gene KL and Marchiafava-Bignami disease.